Aug. 6, 2022
by Bohdana Sokolova
Biopharma insight
New Jersey-based Anima Biotech, a leader in the discovery of small molecule mRNA drugs and their mechanisms of action (MOAs) …
Aug. 5, 2022
by Natalia Honchar
Biopharma insight
Owkin, a biotech startup that uses artificial intelligence (AI) for precision cancer therapy development is partnering with scientists from the …
Aug. 3, 2022
by Natalia Honchar
Biopharma insight
Ginkgo Bioworks, the biotech firm with a platform for cell programming, recently entered into a definitive agreement to acquire a …
Aug. 2, 2022
by Andrii Buvailo
Biopharma insight
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep …
Aug. 1, 2022
by Natalia Honchar
Biopharma insight
Curi Bio, a developer of human stem cell-based platforms for drug discovery, announced the commercial launch of the Mantarray™ platform …
July 29, 2022
by Chris De Savi
Biopharma insight
Lung cancer accounted for 18% of deaths caused by cancer in 2020, making it the leading cause of cancer mortality …
July 28, 2022
by Natalia Honchar
Biopharma insight
Valo Therapeutics Oy (ValoTx), the developer of antigen-coated oncolytic viruses and vaccine vectors as therapeutic vaccines against cancer and infectious …
July 21, 2022
Case study
Sponsored by Cyclica
Cyclica is designing chemical probes for DCAF1, a potentially novel target for protein degradation, with proprietary technology MatchMaker DCAF1 was …
July 20, 2022
by Amandeep Singh
Biopharma insight
The ‘AI in Pharma’ start-up space has been rapidly exploding, with new companies being formed every month. The explosion has …
July 19, 2022
by Natalia Honchar, Andrii Buvailo
Biopharma insight
Shuimu BioSciences, a biotech start-up working towards the implementation of cryo-EM into drug discovery, got an investment from the internet …
July 18, 2022
by Joseph Pareti
Biopharma insight
The motivation for this report In 2018, while at Supercomputing in Dallas I had a couple key encounters that profoundly …
July 15, 2022
by Natalia Honchar
News
Endogena Therapeutics, a biotech company that focuses on the first-in-class endogenous regenerative medicines, just announced treating the first patient with …